IL-25 Induces M2 Macrophages and Reduces Renal Injury in Proteinuric Kidney Disease.

Qi Cao,Changqi Wang,Dong Zheng,Ya Wang,Vincent W. S. Lee,Yuan Min Wang,Guoping Zheng,Thian Kui Tan,Di Yu,Stephen I. Alexander,David C. H. Harris,Yiping Wang

DOI: https://doi.org/10.1681/asn.2010070693

IF: 14.978

2011-01-01

Journal of the American Society of Nephrology

Abstract:The kidney contains receptors for the cytokine IL-25, but the effects of IL-25 in CKD are unknown. Here, we induced adriamycin nephropathy in both BALB/c mice and severe combined immunodeficient (SCID) mice, and we injected IL-25 for 7 consecutive days starting at day 5 after adriamycin administration. BALB/c mice treated with IL-25 had less glomerulosclerosis, tubular atrophy, interstitial expansion, and proteinuria than control mice at day 28. IL-25 increased the levels of IL-4 and IL-13 in serum, kidney, renal draining lymph nodes, and CD4+ lymphocytes. IL-25 also directly suppressed effector macrophages in vitro and in vivo and induced alternatively activated (M2) macrophages in vivo. However, in SCID mice and in BALB/c mice treated with IL-4/13-neutralizing antibody, IL-25 failed to protect against renal injury and did not induce M2. In conclusion, IL-25 protects against renal injury in adriamycin nephropathy in mice by, at least in part, inducing Th2 immune responses.